HomeCompareMTRAF vs JNJ

MTRAF vs JNJ: Dividend Comparison 2026

MTRAF yields 1.63% · JNJ yields 2.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MTRAF wins by $253.7K in total portfolio value
10 years
MTRAF
MTRAF
● Live price
1.63%
Share price
$67.62
Annual div
$1.10
5Y div CAGR
65.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$284.2K
Annual income
$158,361.72
Full MTRAF calculator →
JNJ
Johnson & Johnson
● Live price
2.14%
Share price
$242.49
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.5K
Annual income
$4,749.88
Full JNJ calculator →

Portfolio growth — MTRAF vs JNJ

📍 MTRAF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMTRAFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MTRAF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MTRAF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MTRAF
Annual income on $10K today (after 15% tax)
$138.15/yr
After 10yr DRIP, annual income (after tax)
$134,607.46/yr
JNJ
Annual income on $10K today (after 15% tax)
$182.28/yr
After 10yr DRIP, annual income (after tax)
$4,037.40/yr
At 15% tax rate, MTRAF beats the other by $130,570.06/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MTRAF + JNJ for your $10,000?

MTRAF: 50%JNJ: 50%
100% JNJ50/50100% MTRAF
Portfolio after 10yr
$157.3K
Annual income
$81,555.80/yr
Blended yield
51.84%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

MTRAF
Analyst Ratings
2
Buy
2
Hold
Consensus: Buy
Altman Z
3.9
Piotroski
7/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-5.7% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MTRAF buys
0
JNJ buys
0
No recent congressional trades found for MTRAF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMTRAFJNJ
Forward yield1.63%2.14%
Annual dividend / share$1.10$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR65.3%28%
Portfolio after 10y$284.2K$30.5K
Annual income after 10y$158,361.72$4,749.88
Total dividends collected$251.5K$15.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: MTRAF vs JNJ ($10,000, DRIP)

YearMTRAF PortfolioMTRAF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$10,969$268.66$10,594$274.49+$375.00MTRAF
2$12,192$455.25$11,294$360.69+$898.00MTRAF
3$13,827$781.71$12,133$476.91+$1.7KMTRAF
4$16,164$1,369.60$13,156$635.42+$3.0KMTRAF
5$19,769$2,473.53$14,432$854.61+$5.3KMTRAF
6$25,827$4,673.49$16,056$1,162.76+$9.8KMTRAF
7$37,067$9,432.06$18,175$1,604.53+$18.9KMTRAF
8$60,574$20,912.69$21,009$2,252.68+$39.6KMTRAF
9$117,610$52,796.12$24,911$3,229.73+$92.7KMTRAF
10$284,205$158,361.72$30,458$4,749.88+$253.7KMTRAF

MTRAF vs JNJ: Complete Analysis 2026

MTRAFStock

Metro Inc. operates as a retailer, franchisor, distributor, and manufacturer in the food and pharmaceutical sectors in Canada. It operates supermarkets and discount stores that provide fresh and grocery products, baked goods, prepared foods, meats, dairy products, fruits and vegetables, frozen foods, bakery products, and pastries, as well as Mediterranean and Middle Eastern products. As of September 25, 2021, the company operated a network of approximately 963 food stores under various banners, including Metro, Metro Plus, Super C, and Food Basics, Adonis, and Premiere Moisson as well as approximately 649 drugstores primarily under the Jean Coutu, Brunet, Metro Pharmacy, and Food Basics Pharmacy banners. It also manufactures generic drugs; and provides online grocery shopping services. Metro Inc. was founded in 1947 and is headquartered in Montréal, Canada.

Full MTRAF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this MTRAF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MTRAF vs SCHDMTRAF vs JEPIMTRAF vs OMTRAF vs KOMTRAF vs MAINMTRAF vs ABBVMTRAF vs MRKMTRAF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.